SCHEMBL2931975

SCHEMBL2931975

CCN(CC)c1ccc2[nH]c(Nc3cc(F)cc(F)c3)nc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 1/20 0.44
MAPT P10636 6/20 0.43
HTT P42858 5/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
KDM4E B2RXH2 4/20 0.43
NPC1 O15118 4/20 0.43
LMNA P02545 3/20 0.43
NPSR1 Q6W5P4 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HPGD P15428 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
GAA P10253 2/20 0.43
POLB P06746 2/20 0.43
RAB9A P51151 4/20 0.42
ALDH1A1 P00352 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
CNR1 P21554 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2929609 0.90 MEN1 (0.46) TERTMAPTHTTMEN1KMT2A
SCHEMBL2932965 0.81 MAPT (0.41) TERTMAPTHTTMEN1KMT2A
SCHEMBL2932568 0.76 SMN1; SMN2 (0.41) TERTMAPTHTTMEN1KMT2A
SCHEMBL14693571 0.76 POLB (0.40) HTTNPC1POLBRAB9AMAPK1
SCHEMBL14693610 0.76 POLB (0.40) HTTNPC1POLBRAB9AMAPK1
SCHEMBL2931072 0.75 SMN1; SMN2 (0.46) TERTMAPTHTTMEN1KMT2A
SCHEMBL1996492 0.75 MEN1 (0.60) MAPTMEN1KMT2AKDM4ENPC1
SCHEMBL2931537 0.73 POLB (0.53) MAPTHTTMEN1KMT2AKDM4E
SCHEMBL2926003 0.72 SMN1; SMN2 (0.43) TERTMAPTHTTMEN1KMT2A
SCHEMBL2925719 0.71 MEN1 (0.47) TERTMAPTHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820821-B2 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors TRANSTECH PHARMA, INC. (US) 2010-10-26 US disclosed
US-20100152170-A1 Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors TRANSTECH PHARMA, INC. (US) 2010-06-17 US disclosed
US-20070219235-A1 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors VTVX HOLDINGS I LLC 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152170-A1 Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors AURKC, AURKA, AURKB TERT 1719/4885MAPT 1464/4885HTT 4252/4885
US-20070219235-A1 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors AURKC, AURKA, AURKB TERT 1719/4885MAPT 1464/4885HTT 4252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.